Website intended for a NZ health professional readership
![Brain model [Robina Weermeijer on Unsplash]](/sites/default/files/styles/cropped_image_16_7_/public/2023-10/robina-weermeijer-3KGF9R_0oHs-unsplash.jpg?itok=CAK2Rzd7)
Jim Vause looks a closer look at rapid antigen tests – partly for personal reasons – but finds them a flawed solution for limiting COVID spread
1. Havers FP, Whitaker M, Melgar M, et al. Characteristics and outcomes among adults aged ≥60 years hospitalized with laboratory-confirmed respiratory syncytial virus – RSV-NET, 12 States, July 2022–June 2023. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 2023;72 (40):6 October. Available online: https://www.cdc.gov/mmwr/volumes/72/wr/pdfs/mm7240-H.pdf
2. Wang B, Andraweera P, Elliott S, et al. Asymptomatic SARS-CoV-2 infection by age: A global systematic review and meta-analysis. The Pediatric Infectious Disease Journal 2023:42(3):p 232–39, March. | DOI: 10.1097/INF.0000000000003791 Available online: https://journals.lww.com/pidj/abstract/2023/03000/asymptomatic_sars_cov_2_infection_by_age__a_global.12.aspx?context=featuredarticles&collectionid=3
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
